Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.40
Bid: 1.30
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.20 (15.385%)
Open: 1.40
High: 1.40
Low: 1.40
Prev. Close: 1.40
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Third Point Investors NAV per share drops by quarter

Wed, 26th Apr 2023 14:43

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

IQ-AI Ltd - Jersey-based medical services firm - Revenue for 2022 is GBP535,886, up 2.8% from GBP521,069 the year prior. Pretax loss is GBP511,601, widening from GBP501,058. Loss per share narrows slightly to 0.28p per share, from a loss of 0.29p a year ago. Says focus is on converting as many of its trial sites to long term customers. Says it does not believe that IQ-AI's current market value is a reflection of the accretion of value over the past five years.

----------

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on the field of surgical endoscopy - Revenue grows 8.0% to GBP27.2 million, from GBP25.2 million in 2021. Says it has "made significant progress in establishing sales channels through new products, as well as the development of our commercial footprint". Pretax loss is GBP31.0 million, widening from GBP30.3 million. declares no dividend, unchanged from a year ago. Chief Executive Craig Gulliford says: "We expect to see the continued acceleration of the commercialisation of our core technology and the introduction of new innovative products, as well as the expansion of our Kamaptive programme as we continue to build a world class medical device and tech licensing company."

----------

M&G Credit Income Investment Trust PLC - debt investment firm - Net asset value per share at December 31 94.99 pence, down 6.4% from 101.44p in at December 31 the year prior due to a widening of credit spreads, rather than interest rate rises. NAV total return of negative 2.8%, swinging from a return of 13%. Declares dividend of 5.35p per share "in spite of the company’s underperformance", increasing 32% from 4.04p a year ago, "to reflect" the confidence of its investment manager. Says it expects a rise in NAV as credit spreads normalise.

----------

Third Point Investors Ltd - feeder fund that invests in the Third Point Offshore Fund - Net asset value per share at December 31 USD24.46, down 24% from USD32.37. Returns negative 24% on NAV total return basis, returns negative 26% on share price basis. Notes that "most all asset classes performed poorly", seeing significant losses in all sectors. "While 2022 was extremely disappointing from a performance perspective, the investment manager is encouraged that the opportunity set currently presented is highly attractive for capitalising on its many strategies employed, including security selection and specialist credit," comments Chair Rupert Dorey.

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2022 16:36

IQ-AI imaging technology gets vote of confidence in US study

(Alliance News) - IQ-AI Ltd unit Imaging Biometrics on Tuesday said a study concluded its imaging technology was successful in identifying tumours.

Read more
28 Apr 2022 19:25

TRADING UPDATES: Impellam's first quarter beats pre-virus levels

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Mar 2022 20:30

IN BRIEF: IQ-AI opens oral gallium malotate trial for enrolment

IQ-AI Ltd - Jersey-based medical services firm - Says phase one clinical trial for oral gallium maltolate is open for enrolment. Patient recruitment in the trial is underway and potential volunteers that meet the inclusion criteria have already been identified, it notes. Phase one dose escalation study is designed to determine the optimal dose of GaM that can be administered safely. It is the first-in-human clinical trial for an oral form of GaM to be used in patients with high-grade brain tumours, it adds.

Read more
11 Nov 2021 19:43

TRADING UPDATES: Beximco profit rises; Tremor buoyant as sales rise

TRADING UPDATES: Beximco profit rises; Tremor buoyant as sales rise

Read more
28 Oct 2021 19:19

TRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus

TRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus

Read more
7 Oct 2021 22:08

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit

Read more
22 Sep 2021 19:31

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

Read more
17 Sep 2021 17:53

IN BRIEF: IQ-AI sells several licenses of Imaging Biometrics software

IN BRIEF: IQ-AI sells several licenses of Imaging Biometrics software

Read more
10 Sep 2021 16:14

TRADING UPDATES: Argo gets GBP18 million loan; Genedrive fundraises

TRADING UPDATES: Argo gets GBP18 million loan; Genedrive fundraises

Read more
2 Sep 2021 13:42

EXECUTIVE CHANGES: 600 Group rejigs board; Thor Mining chair resigns

EXECUTIVE CHANGES: 600 Group rejigs board; Thor Mining chair resigns

Read more
1 Sep 2021 14:33

TRADING UPDATES: Trifast buys in US; Eckoh trading meets expectations

TRADING UPDATES: Trifast buys in US; Eckoh trading meets expectations

Read more
27 Aug 2021 14:40

IN BRIEF: IQ-AI interim loss narrows as sales regain lost momentum

IN BRIEF: IQ-AI interim loss narrows as sales regain lost momentum

Read more
16 Jun 2021 17:10

EXECUTIVE CHANGES: Lloyds Banking appoints BT Digital Officer to board

EXECUTIVE CHANGES: Lloyds Banking appoints BT Digital Officer to board

Read more
11 Jun 2021 10:52

SMALL-CAP WINNERS & LOSERS: Robert Walters boosts 2021 profit outlook

SMALL-CAP WINNERS & LOSERS: Robert Walters boosts 2021 profit outlook

Read more
11 Jun 2021 10:34

IQ-AI's medical imaging T1+C software granted a US patent

IQ-AI's medical imaging T1+C software granted a US patent

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.